The Worldwide Endoluminal Suturing Devices Industry is Projected to Reach $139 Million by 2027 - ResearchAndMarkets.com
09 Nov 2022
DUBLIN--(BUSINESS WIRE)--The "Global Endoluminal Suturing Devices Market by Application (Bariatric, Gastrointestinal, Gastroesophageal Reflux Disease), End User (Hospitals, Clinics, Ambulatory Surgical Centers), Technology Analysis, Regulatory Landscape, Trends - Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.
'Global Endoluminal Suturing Devices Market by Application (Bariatric, Gastrointestinal, Gastroesophageal Reflux Disease), End User (Hospitals, Clinics, Ambulatory Surgical Centers), Technology Analysis, Regulatory Landscape, Trends - Forecast to 2027'
The global endoluminal suturing devices market is projected to reach USD 139 million by 2027 from USD 78 million in 2022, at a CAGR of 12.0%.
The growth of this market can largely be attributed to the rising demand for bariatric surgeries, increasing number of surgeries, and rising prevalence of gastrointestinal diseases.
The gastrointestinal surgery segment is expected to register the highest CAGR during the forecast period
Based on application, the global endoluminal suturing devices market is segmented into bariatric surgery, gastrointestinal surgery, gastroesophageal reflux disease surgery, and other surgeries. The gastrointestinal surgery segment is expected to register the highest growth during the forecast period. This is mainly due to the growing number of gastrointestinal cancer cases worldwide.
The ambulatory care centers segment to witness the highest growth in the endoluminal suturing devices end user market during the forecast period
Based on end users, the endoluminal suturing devices market is segmented into hospitals, ambulatory surgical centers, clinics, and other end users. The ambulatory care centers segment is expected to register the highest growth during the forecast period. This can be attributed to the increased adoption of getting treated in ambulatory care settings due to the cost-effective treatment offered.
The APAC to witness the highest growth during the forecast period
Asia Pacific is expected to grow at the highest CAGR during the forecast period of 2022-2027. The presence of high-growth markets such as India, China, and Japan, rapidly developing healthcare industry in China and India, increasing number of hospitals, rising per capita income, increasing healthcare infrastructure, rising burden of GI cancer, and the rising awareness about health are some of the major factors that are expected to drive the growth of the endoluminal suturing devices market in the Asia Pacific region.
Market Dynamics
Increasing Number of Surgical Procedures Worldwide
Rising Prevalence of Gastrointestinal Cancers, Inflammatory Bowel Disease, and Other Digestive Diseases
Favorable Reimbursement Scenario
Restraints
Presence of Alternative Wound Care Management Products
Opportunities
High-Growth Opportunities in Emerging Markets
Increasing Adoption of Outpatient Surgeries
Challenges
Shortage of Skilled Personnel
Companies Mentioned
Ergosuture
Johnson & Johnson (Ethicon, Inc.)
Sutrue Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/2vwq1z
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.